Is there a place for Ulipristal acetate in adenomyosis medical treatment?

Janisse Ferreri, M Gracia, I. Vives, M.J. Martínez-Serrano, F Carmona
2016 · doi:10.13140/rg.2.2.31731.84009 · W6922641323
article OA: gold CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-02 ⓘ

This review examines the existing research on ulipristal acetate's efficacy and safety for managing adenomyosis symptoms and its potential place in treatment algorithms.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

adenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T18:18:06.373866+00:00
License: CC0 · commercial use OK